Issue |
J Extra Corpor Technol
Volume 36, Number 2, June 2004
|
|
---|---|---|
Page(s) | 166 - 168 | |
DOI | https://doi.org/10.1051/ject/2004362166 | |
Published online | 08 August 2023 |
Aortic Valve Replacement for a Patient with Essential Thrombocythemia: A Case Report
HCA Fresenius Medical Care, Extracorporeal Alliance, Wesley Medical Center, Wichita, Kansas
* Address correspondence to: Susan Jones Englert, RN, BSN, CNOR, CCP, Fresenius Medical Care, Extracororeal Alliance, HCA Wesley Medical Center, Wichita, KS 67230. E-mail: sjenglert@cox.net
A 51-year-old male patient with 3+ aortic insufficiency, hepatitis C, osteomyelitis right foot, and a preoperative platelet count 1.3 million/mm3 required cardiopulmonary bypass (CPB). Essential thrombocythemia is a relatively unknown entity with the utilization of CPB. After consulting with the surgeon, an anesthesiologist and another perfusionist, a team approach was used to discuss treatment for this patient during CPB. The treatment consisted of exchange transfusions, autotransfusion techniques, and current protocol for blood gas management. No incidence of hypercoagulability was observed during this procedure or postoperatively. Based on current knowledge of pathophysiology and review of the literature, plateletpheresis should be the current management of essential thrombocythemia.
Key words: aortic valve replacement / essential thrombocythemia / cardiopulmonary bypass
© 2004 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.